Group 1 - The core viewpoint of the article is that Renhe Pharmaceutical has entered into a strategic cooperation agreement with Huajian Medical to explore new models of asset digitization, capitalization, and globalization operations based on blockchain technology in the OTC intellectual property RWA field [1] - The agreement is described as a comprehensive, long-term, and strategic partnership between the two companies [1] - The company clarifies that this agreement does not constitute a significant contract that requires public announcement under relevant regulations and does not have a major impact on the company's current performance [1]